Dalivita, MB - financials and debts

Company age: 4 y. 10 mo.

Update

Dalivita - Company finances

EUR
2021
From: 2021-11-30
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 15,700 9,230 8,740 11,545
Profit before tax -20 9,694 209 1,174 1,173
Net profit -20 9,210 198 1,115 1,103
Equity 80 9,290 9,488 10,603 11,706
Liabilities - 664 11 59 0
Non-current assets 0 0 0 0 0
Current assets 196 9,954 9,499 10,662 11,776
Total assets 196 9,954 9,499 10,662 11,776
Taxes paid
STI taxes - - 490 5 70
Financial indicators
Revenue change y/y - - -41.2% -5.3% +32.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -10.2% 92.5% 2.1% 10.5% 9.4%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -25.0% 99.1% 2.1% 10.5% 9.4%
Profit margin Net profit margin. Shows the overall profitability of the company. - 58.7% 2.1% 12.8% 9.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - 61.7% 2.3% 13.4% 10.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 0.1 0.0 0.0 -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Dalivita - Social security debts

From To Debt, €
2026-05-05 2026-05-31 420.75
2025-05-18 2025-05-31 180.00
2023-07-20 2023-07-31 11.09
2023-07-19 2023-07-19 69.72
2022-08-02 2022-08-31 50.95
2022-05-03 2022-06-30 50.95
2022-03-01 2022-04-30 50.95

Dalivita - VMI tax arrears

As of 2026-09-14, the amount of overdue STI tax debt of the company Dalivita is: 0 €

From To Overdue, €
2026-06-19 2026-09-14 0.06

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Dalivita, MB (code 305944622) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In the latest financial year, 2025, the company generated revenue of €11.5K and net profit of €1.1K, with a profit margin of 9.6%. Revenue increased by 32.1% year on year, and by 25.1% over two years, showing a recovery after the 2024 decline. In 2023, revenue was €9.2K and net profit €198, then in 2024 revenue decreased to €8.7K while net profit rose to €1.1K, indicating improved profitability despite lower sales. The balance sheet remains very strong, with total assets of €11.8K and equity of €11.7K in 2025. Liabilities were minimal in the latest reported year, and the equity ratio stood at 99.4%. Return on equity and return on assets were both 9.4%, and asset turnover was 0.98x, suggesting that assets were used efficiently relative to turnover.